Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity. Ruck T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, et al. Brain 2022;145:1711-1725.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ruck T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, et al. Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity. Brain 2022;145:1711-1725.
PMID: 35661859